Assembly of two distinct dimers and higher-order oligomers from full-length tau

Naruhiko Sahara, Sumihiro Maeda, Miyuki Murayama, Takehiro Suzuki, Naoshi Dohmae, Shu Hui Yen, Akihiko Takashima

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Abnormal accumulation of tau as filamentous structures is a neuropathological hallmark of neurodegenerative diseases referred to as tauopathies. Little is known about the role of native cysteine residues in tau assembly because their substitution with other amino acids has no effect on tau filament morphology. To understand the process involved in tau oligomerization, we analysed both heparin-induced assembly of different forms of recombinant human tau and assembly of tau from COS-7 cells transiently expressing different human tau constructs. Here, we demonstrated that tau assembly involves two distinct dimers (cysteine-dependent and cysteine-independent) that differ in resistance to reduction. During assembly, an increase of cysteine-dependent tau oligomer was observed prior to detection of increased thioflavin T fluorescence signals. The latter event was accompanied by an increase of cysteine-independent dimer. Fewer higher-order oligomers and aggregates were assembled from four-repeat tau containing two amino-terminus inserts that have either the C291A/C322A mutation (cysless-4R2N) or a hexapeptide deletion at residues 306-311 (ΔPHF6-4R2N) compared with those assembled from wild-type tau. Assembly of distinct types of dimers was also observed in lysates from COS-7 cells expressing wild-type 4R2N and brain extracts from mice expressing P301L mutant tau. In contrast, COS-7 cells expressing cysless- or ΔPHF6-4R2N tau contained very little cysteine-dependent dimer. Together, the results indicate that intermolecular disulfide crosslinking along with PHF6 hexapeptide facilitates tau oligomerization and that this event is accompanied by cysteine-independent intermolecular bridging of microtubule-binding domain, leading to assembly of higher-order oligomers. The levels of these dimers may be used to gauge the potential for tau assembly.

Original languageEnglish
Pages (from-to)3020-3029
Number of pages10
JournalEuropean Journal of Neuroscience
Volume25
Issue number10
DOIs
Publication statusPublished - 2007 May
Externally publishedYes

Fingerprint

Cysteine
COS Cells
Tauopathies
Microtubules
Disulfides
Neurodegenerative Diseases
Heparin
Fluorescence
Amino Acids
Mutation
Brain

Keywords

  • Cysteine residue
  • Dimer
  • Human tau
  • PHF6
  • Self-assembly

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Assembly of two distinct dimers and higher-order oligomers from full-length tau. / Sahara, Naruhiko; Maeda, Sumihiro; Murayama, Miyuki; Suzuki, Takehiro; Dohmae, Naoshi; Yen, Shu Hui; Takashima, Akihiko.

In: European Journal of Neuroscience, Vol. 25, No. 10, 05.2007, p. 3020-3029.

Research output: Contribution to journalArticle

Sahara, N, Maeda, S, Murayama, M, Suzuki, T, Dohmae, N, Yen, SH & Takashima, A 2007, 'Assembly of two distinct dimers and higher-order oligomers from full-length tau', European Journal of Neuroscience, vol. 25, no. 10, pp. 3020-3029. https://doi.org/10.1111/j.1460-9568.2007.05555.x
Sahara, Naruhiko ; Maeda, Sumihiro ; Murayama, Miyuki ; Suzuki, Takehiro ; Dohmae, Naoshi ; Yen, Shu Hui ; Takashima, Akihiko. / Assembly of two distinct dimers and higher-order oligomers from full-length tau. In: European Journal of Neuroscience. 2007 ; Vol. 25, No. 10. pp. 3020-3029.
@article{9c6c8709c02e41568116d2d82db3b651,
title = "Assembly of two distinct dimers and higher-order oligomers from full-length tau",
abstract = "Abnormal accumulation of tau as filamentous structures is a neuropathological hallmark of neurodegenerative diseases referred to as tauopathies. Little is known about the role of native cysteine residues in tau assembly because their substitution with other amino acids has no effect on tau filament morphology. To understand the process involved in tau oligomerization, we analysed both heparin-induced assembly of different forms of recombinant human tau and assembly of tau from COS-7 cells transiently expressing different human tau constructs. Here, we demonstrated that tau assembly involves two distinct dimers (cysteine-dependent and cysteine-independent) that differ in resistance to reduction. During assembly, an increase of cysteine-dependent tau oligomer was observed prior to detection of increased thioflavin T fluorescence signals. The latter event was accompanied by an increase of cysteine-independent dimer. Fewer higher-order oligomers and aggregates were assembled from four-repeat tau containing two amino-terminus inserts that have either the C291A/C322A mutation (cysless-4R2N) or a hexapeptide deletion at residues 306-311 (ΔPHF6-4R2N) compared with those assembled from wild-type tau. Assembly of distinct types of dimers was also observed in lysates from COS-7 cells expressing wild-type 4R2N and brain extracts from mice expressing P301L mutant tau. In contrast, COS-7 cells expressing cysless- or ΔPHF6-4R2N tau contained very little cysteine-dependent dimer. Together, the results indicate that intermolecular disulfide crosslinking along with PHF6 hexapeptide facilitates tau oligomerization and that this event is accompanied by cysteine-independent intermolecular bridging of microtubule-binding domain, leading to assembly of higher-order oligomers. The levels of these dimers may be used to gauge the potential for tau assembly.",
keywords = "Cysteine residue, Dimer, Human tau, PHF6, Self-assembly",
author = "Naruhiko Sahara and Sumihiro Maeda and Miyuki Murayama and Takehiro Suzuki and Naoshi Dohmae and Yen, {Shu Hui} and Akihiko Takashima",
year = "2007",
month = "5",
doi = "10.1111/j.1460-9568.2007.05555.x",
language = "English",
volume = "25",
pages = "3020--3029",
journal = "European Journal of Neuroscience",
issn = "0953-816X",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Assembly of two distinct dimers and higher-order oligomers from full-length tau

AU - Sahara, Naruhiko

AU - Maeda, Sumihiro

AU - Murayama, Miyuki

AU - Suzuki, Takehiro

AU - Dohmae, Naoshi

AU - Yen, Shu Hui

AU - Takashima, Akihiko

PY - 2007/5

Y1 - 2007/5

N2 - Abnormal accumulation of tau as filamentous structures is a neuropathological hallmark of neurodegenerative diseases referred to as tauopathies. Little is known about the role of native cysteine residues in tau assembly because their substitution with other amino acids has no effect on tau filament morphology. To understand the process involved in tau oligomerization, we analysed both heparin-induced assembly of different forms of recombinant human tau and assembly of tau from COS-7 cells transiently expressing different human tau constructs. Here, we demonstrated that tau assembly involves two distinct dimers (cysteine-dependent and cysteine-independent) that differ in resistance to reduction. During assembly, an increase of cysteine-dependent tau oligomer was observed prior to detection of increased thioflavin T fluorescence signals. The latter event was accompanied by an increase of cysteine-independent dimer. Fewer higher-order oligomers and aggregates were assembled from four-repeat tau containing two amino-terminus inserts that have either the C291A/C322A mutation (cysless-4R2N) or a hexapeptide deletion at residues 306-311 (ΔPHF6-4R2N) compared with those assembled from wild-type tau. Assembly of distinct types of dimers was also observed in lysates from COS-7 cells expressing wild-type 4R2N and brain extracts from mice expressing P301L mutant tau. In contrast, COS-7 cells expressing cysless- or ΔPHF6-4R2N tau contained very little cysteine-dependent dimer. Together, the results indicate that intermolecular disulfide crosslinking along with PHF6 hexapeptide facilitates tau oligomerization and that this event is accompanied by cysteine-independent intermolecular bridging of microtubule-binding domain, leading to assembly of higher-order oligomers. The levels of these dimers may be used to gauge the potential for tau assembly.

AB - Abnormal accumulation of tau as filamentous structures is a neuropathological hallmark of neurodegenerative diseases referred to as tauopathies. Little is known about the role of native cysteine residues in tau assembly because their substitution with other amino acids has no effect on tau filament morphology. To understand the process involved in tau oligomerization, we analysed both heparin-induced assembly of different forms of recombinant human tau and assembly of tau from COS-7 cells transiently expressing different human tau constructs. Here, we demonstrated that tau assembly involves two distinct dimers (cysteine-dependent and cysteine-independent) that differ in resistance to reduction. During assembly, an increase of cysteine-dependent tau oligomer was observed prior to detection of increased thioflavin T fluorescence signals. The latter event was accompanied by an increase of cysteine-independent dimer. Fewer higher-order oligomers and aggregates were assembled from four-repeat tau containing two amino-terminus inserts that have either the C291A/C322A mutation (cysless-4R2N) or a hexapeptide deletion at residues 306-311 (ΔPHF6-4R2N) compared with those assembled from wild-type tau. Assembly of distinct types of dimers was also observed in lysates from COS-7 cells expressing wild-type 4R2N and brain extracts from mice expressing P301L mutant tau. In contrast, COS-7 cells expressing cysless- or ΔPHF6-4R2N tau contained very little cysteine-dependent dimer. Together, the results indicate that intermolecular disulfide crosslinking along with PHF6 hexapeptide facilitates tau oligomerization and that this event is accompanied by cysteine-independent intermolecular bridging of microtubule-binding domain, leading to assembly of higher-order oligomers. The levels of these dimers may be used to gauge the potential for tau assembly.

KW - Cysteine residue

KW - Dimer

KW - Human tau

KW - PHF6

KW - Self-assembly

UR - http://www.scopus.com/inward/record.url?scp=34249990083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249990083&partnerID=8YFLogxK

U2 - 10.1111/j.1460-9568.2007.05555.x

DO - 10.1111/j.1460-9568.2007.05555.x

M3 - Article

C2 - 17561815

AN - SCOPUS:34249990083

VL - 25

SP - 3020

EP - 3029

JO - European Journal of Neuroscience

JF - European Journal of Neuroscience

SN - 0953-816X

IS - 10

ER -